Download PDF
The Journal of Hip Surgery 2020; 04(02): 094-100
DOI: 10.1055/s-0040-1712521
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Revision Total Hip Arthroplasty in Osteogenesis Imperfecta

Lauren H. Schoof
1   Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York
,
Matthew L. Duenes
1   Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York
,
James E. Feng
1   Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York
2   Department of Orthopaedic Surgery, Beaumont Health, Royal Oak, Michigan
,
William J. Long
1   Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York
,
Ran Schwarzkopf
1   Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York
› Author Affiliations
Further Information

Publication History

15 June 2019

04 March 2020

Publication Date:
11 June 2020 (online)

   Permissions and Reprints

Abstract

Osteogenesis imperfecta (OI) is a rare group of connective tissue disorders commonly associated with bone fragility, deformity, and fractures, leading to instability and early osteoarthritis. Current advancements in the medical and surgical management of OI have extended the life span of these patients, resulting in an increased need for joint arthroplasty to help maintain quality of life. However, surgery among this patient population is technically challenging and comes with a high burden of revision. In this report, we present a case of revision total hip arthroplasty in a patient with OI and review important considerations to help ensure proper preoperative planning and correct precautions to minimize complications and decrease implant failure.

Keywords

osteogenesis imperfecta - revision hip arthroplasty - bone fragility - complex total hip arthroplasty
 

  • References

  • 1 Tosi LL, Oetgen ME, Floor MK. , et al. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis 2015; 10 (01) 146
    CrossrefPubMedGoogle Scholar
  • 2 Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 2011; 7 (09) 540-557
    CrossrefPubMedGoogle Scholar
  • 3 Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004; 363 (9418): 1377-1385
    CrossrefPubMedGoogle Scholar
  • 4 Singer RB, Ogston SA, Paterson CR. Mortality in various types of osteogenesis imperfecta. J Insur Med 2001; 33 (03) 216-220
    PubMedGoogle Scholar
  • 5 Paterson CR, Ogston SA, Henry RM. Life expectancy in osteogenesis imperfecta. BMJ 1996; 312 (7027): 351
    CrossrefPubMedGoogle Scholar
  • 6 Palomo T, Vilaça T, Lazaretti-Castro M. Osteogenesis imperfecta: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 2017; 24 (06) 381-388
    CrossrefPubMedGoogle Scholar
  • 7 Papagelopoulos PJ, Morrey BF. Hip and knee replacement in osteogenesis imperfecta. J Bone Joint Surg Am 1993; 75 (04) 572-580
    CrossrefPubMedGoogle Scholar
  • 8 Marini JC, Forlino A, Bächinger HP. , et al. Osteogenesis imperfecta. Nat Rev Dis Primers 2017; 3: 17052
    CrossrefPubMedGoogle Scholar
  • 9 Stevenson DA, Carey JC, Byrne JLB, Srisukhumbowornchai S, Feldkamp ML. Analysis of skeletal dysplasias in the Utah population. Am J Med Genet A 2012; 158A (05) 1046-1054
    CrossrefPubMedGoogle Scholar
  • 10 Moffitt KB, Abiri OO, Scheuerle AE, Langlois PH. Descriptive epidemiology of selected heritable birth defects in Texas. Birth Defects Res A Clin Mol Teratol 2011; 91 (12) 990-994
    CrossrefPubMedGoogle Scholar
  • 11 Krishnan H, Patel NK, Skinner JA. , et al. Primary and revision total hip arthroplasty in osteogenesis imperfecta. Hip Int 2013; 23 (03) 303-309
    CrossrefPubMedGoogle Scholar
  • 12 Roberts TT, Cepela DJ, Uhl RL, Lozman J. Orthopaedic considerations for the adult with osteogenesis imperfecta. J Am Acad Orthop Surg 2016; 24 (05) 298-308
    CrossrefPubMedGoogle Scholar
  • 13 King JD, Bobechko WP. Osteogenesis imperfecta: an orthopaedic description and surgical review. J Bone Jt Surg 1971; 53B (01) 72-89
    PubMedGoogle Scholar
  • 14 Ahn J, Carter E, Raggio CL, Green DW. Acetabular protrusio in patients with osteogenesis imperfecta: risk factors and progression. J Pediatr Orthop 2017 (e-pub ahead of print). Doi: 10.1097/bpo.0000000000001051
    PubMedGoogle Scholar
  • 15 McBride MT, Muldoon MP, Santore RF, Trousdale RT, Wenger DR. Protrusio acetabuli: diagnosis and treatment. J Am Acad Orthop Surg 2001; 9 (02) 79-88
    CrossrefPubMedGoogle Scholar
  • 16 Mullaji AB, Shetty GM. Acetabular protrusio: surgical technique of dealing with a problem in depth. Bone Joint J 2013; 95-B (11, Suppl A ): 37-40
    CrossrefPubMedGoogle Scholar
  • 17 Davidson D, Pike J, Garbuz D, Duncan CP, Masri BA. Intraoperative periprosthetic fractures during total hip arthroplasty. Evaluation and management. J Bone Joint Surg Am 2008; 90 (09) 2000-2012
    CrossrefPubMedGoogle Scholar
  • 18 Berry DJ. Epidemiology: hip and knee. Orthop Clin North Am 1999; 30 (02) 183-190
    CrossrefPubMedGoogle Scholar
  • 19 Bottai V, Dell'Osso G, Celli F. , et al. Total hip replacement in osteoarthritis: the role of bone metabolism and its complications. Clin Cases Miner Bone Metab 2015; 12 (03) 247-250
    PubMedGoogle Scholar
  • 20 Mäkelä KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg Am 2008; 90 (10) 2160-2170
    CrossrefPubMedGoogle Scholar
  • 21 Sandiford NA, Garbuz DS, Masri BA, Duncan CP. Nonmodular tapered fluted titanium stems osseointegrate reliably at short term in revision THAs. Clin Orthop Relat Res 2017; 475 (01) 186-192
    CrossrefPubMedGoogle Scholar
  • 22 Huang Y, Shao H, Zhou Y, Gu J, Tang H, Yang D. Femoral bone remodeling in revision total hip arthroplasty with use of modular compared with monoblock tapered fluted titanium stems: the role of stem length and stiffness. J Bone Joint Surg Am 2019; 101 (06) 531-538
    CrossrefPubMedGoogle Scholar
  • 23 Weeden SH, Paprosky WG. Minimal 11-year follow-up of extensively porous-coated stems in femoral revision total hip arthroplasty. J Arthroplasty 2002; 17 (04) (Suppl. 01) 134-137
    CrossrefPubMedGoogle Scholar
  • 24 Herry Y, Viste A, Bothorel H, Desmarchelier R, Fessy MH. Long-term survivorship of a monoblock long cementless stem in revision total hip arthroplasty. Int Orthop 2019; 43 (10) 2279-2284
    CrossrefPubMedGoogle Scholar
  • 25 Biggin A, Munns CF. Long-term bisphosphonate therapy in osteogenesis imperfecta. Curr Osteoporos Rep 2017; 15 (05) 412-418
    CrossrefPubMedGoogle Scholar
  • 26 Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 2014; (07) CD005088
    PubMedGoogle Scholar
  • 27 Lozano-Calderon SA, Colman MW, Raskin KA, Hornicek FJ, Gebhardt M. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls. Orthop Clin North Am 2014; 45 (03) 403-416
    CrossrefPubMedGoogle Scholar
  • 28 Cavalli L, Brandi ML. Periprosthetic bone loss: diagnostic and therapeutic approaches. F1000 Res 2014; 2: 266
    CrossrefPubMedGoogle Scholar
  • 29 Muratore M, Quarta E, Quarta L. , et al. Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening. Clin Cases Miner Bone Metab 2012; 9 (01) 50-55
    PubMedGoogle Scholar
  • 30 Bhandari M, Bajammal S, Guyatt GH. , et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am 2005; 87 (02) 293-301
    CrossrefPubMedGoogle Scholar
  • 31 Prieto-Alhambra D, Lalmohamed A, Abrahamsen B. , et al. Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort. Arthritis Rheumatol 2014; 66 (11) 3233-3240
    PubMedGoogle Scholar
  • 32 Prieto-Alhambra D, Javaid MK, Judge A. , et al. Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum 2011; 63 (04) 992-1001
    CrossrefPubMedGoogle Scholar
  • 33 Prieto-Alhambra D, Kassim Javaid M, Judge A. , et al. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 2012; 343: d7222
    PubMedGoogle Scholar
  • 34 Lin T, Yan SG, Cai XZ, Ying ZM. Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials. Osteoporos Int 2012; 23 (06) 1823-1834
    CrossrefPubMedGoogle Scholar
  • 35 Khatod M, Inacio MCS, Dell RM, Bini SA, Paxton EW, Namba RS. Association of bisphosphonate use and risk of revision after THA: outcomes from a US Total Joint Replacement Registry. Clin Orthop Relat Res 2015; 473 (11) 3412-3420
    CrossrefPubMedGoogle Scholar
  • 36 Teng S, Yi C, Krettek C, Jagodzinski M. Bisphosphonate use and risk of implant revision after total hip/knee arthroplasty: a meta-analysis of observational studies. PLoS One 2015; 10 (10) e0139927
    CrossrefPubMedGoogle Scholar
  • 37 Desai PA, Vyas PA, Lane JM. Atypical femoral fractures: a review of the literature. Curr Osteoporos Rep 2013; 11 (03) 179-187
    CrossrefPubMedGoogle Scholar